PMC:7188654 / 12643-13603
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T48 | 803-808 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T31 | 803-808 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T107 | 84-85 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T108 | 237-239 | http://purl.obolibrary.org/obo/CLO_0009877 | denotes | NY |
| T109 | 268-274 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T110 | 312-316 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T111 | 615-616 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T112 | 620-624 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T113 | 643-651 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test, as |
| T114 | 696-704 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test was |
| T115 | 736-737 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T116 | 759-767 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test was |
| T117 | 803-808 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T118 | 803-808 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
| T119 | 809-813 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T17 | 237-239 | Chemical | denotes | NY | http://purl.obolibrary.org/obo/CHEBI_73427 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T91 | 0-20 | Sentence | denotes | Statistical analysis |
| T92 | 21-241 | Sentence | denotes | The clinical data were prospectively recorded and tabulated in a Microsoft Excel database (Microsoft Corp, Redmond, Wash).9 Statistical analysis was performed using SPSS, release 25.0, for Windows (IBM Corp, Armonk, NY). |
| T93 | 242-317 | Sentence | denotes | Continuous variables were tested for normality using the Shapiro-Wilk test. |
| T94 | 318-416 | Sentence | denotes | Variables that were normally distributed are presented as the mean ± standard deviation and range. |
| T95 | 417-504 | Sentence | denotes | Non-normally distributed variables are presented as the median and interquartile range. |
| T96 | 505-572 | Sentence | denotes | Categorical variables are presented as frequencies and percentages. |
| T97 | 573-662 | Sentence | denotes | Categorical variables were analyzed using a χ2 test or Fisher's exact test, as necessary. |
| T98 | 663-735 | Sentence | denotes | An independent samples Student t test was used for continuous variables. |
| T99 | 736-857 | Sentence | denotes | A Wilcoxon signed-rank test was used to evaluate the difference in blood test results before and after revascularization. |
| T100 | 858-960 | Sentence | denotes | All reported P values are two-sided, and P < .05 was considered to indicate statistical significance.9 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32360679-25971435-65359930 | 143-144 | 25971435 | denotes | 9 |
| 32360679-25971435-65359931 | 959-960 | 25971435 | denotes | 9 |